96 First clinical results for a novel antiviral treatment for hepatitis C: A phase I/II dose escalation trial assessing tolerance, pharmacokinetics, and antiviral activity of NM283

Authors:
  • EGE. Godofsky
    E. Godofsky
  • NAN. Afdhal
    N. Afdhal
  • VRV. Rustgi
    V. Rustgi
  • LSL. Shick
    L. Shick
  • LDL. Duncan
    L. Duncan
  • XZX.J. Zhou
    X.J. Zhou
  • GCG. Chao
    G. Chao
  • CFC. Fang
    C. Fang
  • BFB. Fielman
    B. Fielman
  • MMM. Myers
    M. Myers
  • NBN.A. Brown
    N.A. Brown

Abstract
No abstract available